Heidi Kosiorek Selected Research

Interferons

10/2019

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heidi Kosiorek Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 05/2017
4	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 01/2019
3	Polycythemia Vera 11/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 12/2019 - 11/2017
2	Thrombocytopenia (Thrombopenia) 12/2017 - 01/2017
1	Urinary Retention 04/2024
1	Colorectal Neoplasms (Colorectal Cancer) 02/2024
1	Polyuria 01/2023
1	Diabetes Insipidus 01/2023
1	Cholangiocarcinoma 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2021
1	Diabetes Mellitus 02/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021
1	Adenocarcinoma 01/2021
1	Rosacea (Acne Rosacea) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2019
1	Essential Thrombocythemia 10/2019
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2019
1	Inflammation (Inflammations) 06/2019
1	Leukopenia 12/2017
1	Anemia 12/2017
1	Infections 10/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2017
1	Autoimmune Diseases (Autoimmune Disease) 07/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2017
1	Fibrosis (Cirrhosis) 06/2017
1	Hemorrhage 01/2017
1	Thrombosis (Thrombus) 01/2017
1	Splenomegaly 01/2016

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 01/2023 - 01/2021
2	RG7388IBA 11/2020 - 01/2019
2	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2019 - 01/2016
2	Syntex adjuvant formulationIBA 12/2017 - 01/2016
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	Hypnotics and Sedatives (Sedatives)IBA 01/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	ponatinibIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 02/2021
1	Hemoglobins (Hemoglobin)IBA 02/2021
1	Circulating Tumor DNAIBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2020
1	Protons (Proton)IBA 01/2020
1	HydrogelsIBA 01/2020
1	InterferonsIBA 10/2019
1	peginterferon alfa-2a (Pegasys)FDA Link 10/2019
1	Interleukin-6 (Interleukin 6)IBA 06/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2019
1	lestaurtinibIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	Azathioprine (Imuran)FDA LinkGeneric 07/2017
1	Immunomodulating AgentsIBA 07/2017
1	CoagulantsIBA 06/2017
1	Janus Kinase InhibitorsIBA 01/2016

Therapy/Procedure

5	Therapeutics 10/2019 - 01/2016
2	Cell Transplantation 10/2020 - 05/2017
2	Erythrocyte Transfusion 12/2017 - 01/2017
1	Knee Replacement Arthroplasty (Total Knee Replacement) 04/2024
1	Arthroplasty 04/2024
1	Adjuvant Chemotherapy 02/2024
1	Glycemic Control 02/2021
1	Transplantation 10/2020
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2020
1	Proton Therapy 01/2020
1	Radiotherapy 01/2020
1	Mastectomy (Mammectomy) 12/2019
1	Mammaplasty (Breast Reconstruction) 12/2019
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Contraindications 11/2017
1	Length of Stay 10/2017
1	Sphincterotomy 06/2017
1	Salvage Therapy 05/2017
1	Drug Therapy (Chemotherapy) 05/2017